Baseline characteristics
| Variable | Overall cohort (n=478) | GI symptoms (n=161) | No GI symptoms (n=317) | p value (chi-squared test) | Odds ratio (95% CI) |
|---|---|---|---|---|---|
| Age, median (IQR) | 70 (23.0) | 68 (23.0) | 72 (22.5) | 0.18 | |
| Male, median (IQR) | 279 (58.4) | 87 (54.0) | 192 (60.6) | 0.17 | 0.8 (0.5–1.1) |
| BMI ≥25, n | 401 | 143 | 258 | ||
| Number (%) | 253 (63.1) | 100 (69.9) | 153 (59.3) | 0.04 | 1.6 (1.0–2.5) |
| Usual residence | <0.0001 | ||||
| Own home – number (%) | 309 (64.6) | 124 (77) | 185 (58.4) | 1.0 Reference group | |
| Own home with carers – number (%) | 86 (18) | 23 (14.3) | 63 (19.9) | 0.5 (0.3–0.9) | |
| Residential home – number (%) | 25 (5.2) | 5 (3.1) | 20 (6.3) | 0.4 (0.1–1.0) | |
| Nursing home – number (%) | 58 (12.1) | 9 (5.6) | 49 (15.5) | 0.3 (0.1–0.6) | |
| Clinical frailty score, median (IQR) [total n] | 4 (4) [476] | 3 (4) [160] | 5 (4) [316] | 0.02 | |
| DNAR, number (%) | 286 (59.8) | 80 (49.7) | 206 (65.0) | 0.001 | 0.5 (0.4–0.8) |
| Community-acquired COVID-19 (14 days between admission and positive swab) – number (%) | 423 (88.5) | 152 (94.4) | 271 (85.5) | 0.004 | 2.9 (1.4–6.0) |